NYSE: ECVTEcovyst Inc Stock
$9.83-0.09 (-0.91%)
Updated Apr 17, 2024
ECVT Price
$9.83
Fair Value Price
N/A
Market Cap
$1.15B
52 Week Low
$8.26
52 Week High
$12.35
P/E
16.38x
P/B
1.63x
P/S
1.67x
PEG
0.29x
Dividend Yield
N/A
Revenue
$691.12M
Earnings
$71.15M
Gross Margin
28.6%
Operating Margin
18.33%
Profit Margin
10.3%
Debt to Equity
1.61
Operating Cash Flow
$138M
Beta
1.05
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A
ECVT Overview
Ecovyst Inc. manufactures specialty inorganic performance chemicals, specialty catalysts, and specialty glass materials. Known as PQ Group Holdings Inc. until 2021/08, Ecovyst Inc. was founded in 1831 and is headquartered in Malvern, PA.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ECVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ECVT ($9.83) is trading below its intrinsic value of $15.06, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ECVT is good value based on its earnings relative to its share price (16.38x), compared to the US market average (41.64x)
P/E vs Market Valuation
ECVT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ECVT due diligence checks available for Premium users.
Be the first to know about important ECVT news, forecast changes, insider trades & much more!
ECVT News
Valuation
ECVT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
16.38x
Industry
30.48x
Market
41.64x
ECVT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ECVT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ECVT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.63x
Industry
3.36x
ECVT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ECVT price to earnings growth (PEG)
For valuing profitable companies with growth potential
ECVT is good value based... subscribe to Premium to read more.
PEG Value Valuation
ECVT's financial health
Profit margin
Revenue
$172.8M
Net Income
$29.9M
Profit Margin
17.3%
ECVT's Earnings (EBIT) of $126.67M... subscribe to Premium to read more.
Interest Coverage Financials
ECVT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.8B
Liabilities
$1.1B
Debt to equity
1.61
ECVT's short-term assets ($245.99M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ECVT's long-term liabilities ($1.01B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ECVT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ECVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$64.2M
Investing
-$11.7M
Financing
-$3.0M
ECVT's operating cash flow ($137.60M)... subscribe to Premium to read more.
Debt Coverage Financials
ECVT vs Specialty Chemical Stocks
Ecovyst Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.